- $140.17m
- $126.13m
- $70.39m
Brief: Codexis Appoints Margaret Fitzgerald As Chief Legal Officer And General Counsel
Brief: Codexis Announces Appointment Of Kevin Norrett As Chief Operating Officer
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Coupa Software, Docusign
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Coupa Software, Docusign
Brief: Codexis Reports Second Quarter 2022 Financial Results
Brief: Codexis And Molecular Assemblies Announce Execution Of Commercial License And Enzyme Supply Agreement For Optimized Tdt Enzyme For Enzymatic Dna Synthesis
Brief: Codexis Inc Says John Nicols Will Retire As CEO For Family Reasons
U.S. STOCKS ON THE MOVE-Neximmune Inc, Zymeworks Inc,
Codexis slumps on forecast downgrade, PT cuts
U.S. RESEARCH ROUNDUP- Cintas, JP Morgan, PayPal Holdings
Brief: Codexis Reports Agreement With Pfizer To Supply Enzyme For Manufacture Of Paxlovid
Brief: Codexis Reports Prelim Q2 2022 Results
Brief: Codexis Q1 Loss Per Share $0.13
Codexis Inc reports results for the quarter ended in March - Earnings Summary
Codexis Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Codexis And seqWell Announce Strategic Investment And Partnership Initiation
Brief: Codexis And seqWell Announce Strategic Investment And Partnership Initiation
Brief: Codexis, Molecular Assemblies Report Results Of First Collaboration
U.S. RESEARCH ROUNDUP- Codexis, Ionis Pharmaceuticals, Travere Therapeutics